Testicular dysgenesis syndrome and phthalate exposure: A review of literature
Abstract
Endocrine disruptors are chemicals that interfere with the body’s endocrine system and cause adverse effects in biological systems. Phthalates are a group of man-made chemicals which are mainly used as plasticizers and classified as endocrine disruptors. They are also used in cosmetic and personal care products as color or smell fixators. Moreover, phthalates are present in inks, adhesives, sealants, automobile parts, tools, toys, carpets, medical tubing and blood storage bags, and food packages. Pathological condition known as “testicular dysgenesis syndrome” (TDS) or “phthalate syndrome” is usually linked to phthalate exposure and is coined to describe the rise in alterations in reproductive health in men, such as reduced semen quality (decrease in sperm counts, sperm motility and increase in abnormal sperms), hypospadias, cryptorchidism, reduced anogenital distance and early-life testicular cancer. Phthalates are suggested to cause direct effect on gonadal and non-gonadal tissues, impair the differentiation and morphogenesis of seminiferous tubules and accessory sex organs and testicular cells (both Sertoli and Leydig cells), alter estradiol and/or testosterone levels, decrease insulin-like 3 (INSL3) peptide production, impair spermatogenesis and lead to epigenetic alterations, all of which may lead to TDS. This review will mainly focus on phthalates as causes of TDS and their mechanisms of action.
References
McLaughlin D. Fooling with Nature: Silent Spring Revisited. Frontline PBS 2010. [Internet] [cited 2021 Oct 10] Available from: https://www.pbs.org/wgbh/pages/frontline/shows/nature/disrupt/sspring.html Last accessed: 12/21/2021.
Glausiusz J. Better Planet: Can A Maligned Pesticide Save Lives? [Internet]. Discover Magazine; 2007 [cited 2021 Oct 10]. Available from: https://www.discovermagazine.com/environment/can-a-maligned-pesticide-save-lives.>
Paull J. The Rachel Carson Letters and the Making of Silent Spring. SAGE Journals. 2013;3(3):1-12.
US EPA. DDT-A Brief History and Status [Internet]. 2021 [cited 2021 Oct 10]. Available from: https://www.epa.gov/ingredients-used-pesticide-products/ddt-brief-history-and-status.>
Lambert JQT. Rehabilitating Carson [Internet]. 2008 [cited 2021 Oct 10]. Available from: https://www.prospectmagazine.co.uk/magazine/rehabilitatingcarson.>
International Programme On Chemical Safety DDT and its derivatives. Environmental Health Criteria monograph No. 009 [Internet]. 1979 [cited 2021 Oct 10]. Available from: https://inchem.org/documents/ehc/ehc/ehc009.htm.>
Lammel G, Klánová J, Erić L, Ilić P, Kohoutek J, Kovacić I. Sources of organochlorine pesticides in air in an urban Mediterranean environment: volatilisation from soil. J Environ Monit. 2011;13(12):3358-64.
Report on Carcinogens. Dichlorodiphenyltrichloroethane [Internet]. National Toxicology Program, Department of Health and Human Services; 2014 [cited 2021 Oct 10]. Available from: https://ntp.niehs.nih.gov/ntp/roc/content/profiles/dichlorodiphenyltrichloroethane.pdf.>
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . DDT, Lindane, and 2,4-D. Lyon (FR): International Agency for Research on Cancer. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 113.) [Internet]. 2018; [cited 2021 Oct 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507424/>
Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature. 1995;375(6532):581-5.
Cohn BA, La Merrill M, Krigbaum NY, Yeh G, Park JS, Zimmermann L, et al. DDT Exposure in Utero and Breast Cancer. J Clin Endocrinol Metab. 2015;100(8):2865-72.
National Institute of Environmental Health Sciences [Internet]. Endocrine Disruptors; 2016 [cited 2021 Oct 10]. Available from: https://web.archive.org/web/20160305203707/http://gewa.mpcer.nau.edu/files/endocrine-disruptors.pdf.>
US EPA [Internet]. Research on Endocrine Disruptors; 2020 [cited 2021 Oct 10]. Available from: https://www.epa.gov/chemical-research/research-endocrine-disruptors.>
WHO International Programme on Chemical Safety [Internet]. Global Assessment of the State-of-Science of Endocrine Disruptors; 2002 [cited 2021 Oct 10]. Available from: https://www.who.int/ipcs/publications/en/toc.pdf?ua=1.>
Sharpe RM, Franks S. Environment, lifestyle and infertility an inter-generational issue. Nat Cell Biol. 2002;4 Suppl:s33-40.
Amaral Mendes JJ. The endocrine disrupters: a major medical challenge. Food Chem Toxicol. 2002;40(6):781-8.
Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16(5):972-8.
Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril. 2008;89(2 Suppl):e33-8.
Erkekoglu, P, BelmaKoçer G. Testicular Dysgenesis Syndrome and Phthalates: Where do we Stand. J Genit Syst Disor. 2015;4:1.
Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. The Lancet. 2004;363(9417):1264-9.
Boisen KA, Chellakooty M, Schmidt IM, Kai CM, Damgaard IN, Suomi AM, et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab. 2005;90(7):4041-6.
Richiardi L, Bellocco R, Adami H-O, Torrång A, Barlow L, Hakulinen T, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2157-66.
Hemminki K, Li X. Cancer risks in Nordic immigrants and their offspring in Sweden. European journal of cancer. 2002;38(18):2428-34.
Howdeshell KL, Furr J, Lambright CR, Rider CV, Wilson VS, Gray Jr LE. Cumulative effects of dibutyl phthalate and diethylhexyl phthalate on male rat reproductive tract development: altered fetal steroid hormones and genes. Toxicol Sci. 2007;99(1):190-202.
Hutson JM, Williams M, Fallat ME, Attah A. Testicular descent: new insights into its hormonal control. Oxf Rev Reprod Biol. 1990;12:1-56.
Rivas A, Fisher JS, McKinnell C, Atanassova N, Sharpe RM. Induction of reproductive tract developmental abnormalities in the male rat by lowering androgen production or action in combination with a low dose of diethylstilbestrol: evidence for importance of the androgen-estrogen balance. Endocrinology. 2002;143(12):4797-808.
Center of Disease Control an Prevention [Internet]. Phthalates Factsheet; 2021 [cited 2021 Oct 10]. Available from: https://www.cdc.gov/biomonitoring/Phthalates_FactSheet.html.>
Agency for Toxic Substances and Disease Registry [Internet]. Toxicological Profile for Di(2- ethylhexyl)phthalate. Atlanta, GA.: Public Health Service, U.S. Department of Health and Human Services; 2019 [cited 2021 Oct 10]. Available from: https://www.atsdr.cdc.gov/toxprofiles/tp9.pdf.>
US EPA [Internet]. Bis(2-ethylhexyl) phthalate (DEHP); 2016 [cited 2021 Oct 10]. Available from: https://www.epa.gov/sites/default/files/2016-09/documents/bis-2-ethylhexyl-phthalate.pdf.>
Centers for Disease Control and Prevention Program [Internet]. Phthalates; 2009 [cited 2021 Oct 10]. Available from: https://www.cdc.gov/biomonitoring/pdf/pthalates_factsheet.pdf.>
European Chemicals Bureau [Internet]. Dibuthyl Phthalate; 2004 [cited 2021 Oct 10]. Available from: https://echa.europa.eu/documents/10162/04f79b21-0b6d-4e67-91b9-0a70d4ea7500.>
Kay VR, Chambers C, Foster WG. Reproductive and developmental effects of phthalate diesters in females. Crit Rev Toxicol. 2013;43(3):200-19.
Yalçin SS, Erdal İ, Çetinkaya S, Oğuz B. Urinary levels of phthalate esters and heavy metals in adolescents with thyroid colloid cysts. Int J Environ Health Res. 2021 Feb 8:1-14. doi: 10.1080/09603123.2021.1883554. Epub ahead of print.
Hauser R, Calafat A. Phthalates and human health. Occup Environ Med. 2005;62(11):806-18.
Balbuena P, Campbell Jr J, Clewell III HJ, Clewell RA. Evaluation of a predictive in vitro Leydig cell assay for anti-androgenicity of phthalate esters in the rat. Toxicol In Vitro. 2013;27(6):1711-8.
Christiansen S, Boberg J, Axelstad M, Dalgaard M, Vinggaard AM, Metzdorff SB, et al. Low-dose perinatal exposure to di (2-ethylhexyl) phthalate induces anti-androgenic effects in male rats. Reprod Toxicol. 2010;30(2):313-21.
Erkekoglu P, Zeybek ND, Giray B, Asan E, Arnaud J, Hincal F. Reproductive toxicity of di (2-ethylhexyl) phthalate in selenium-supplemented and selenium-deficient rats. Drug Chem Toxicol. 2011;34(4):379-89.
Kortenkamp A, Faust M. Combined exposures to anti‐androgenic chemicals: steps towards cumulative risk assessment. Int J Androl. 2010;33(2):463-74.
Svechnikov K, Svechnikova I, Söder O. Inhibitory effects of mono-ethylhexyl phthalate on steroidogenesis in immature and adult rat Leydig cells in vitro. Reprod Toxicol. 2008;25(4):485-90.
Buluş AD, Aşci A, Erkekoglu P, Balci A, Andiran N, Koçer-Gümüşel B. The evaluation of possible role of endocrine disruptors in central and peripheral precocious puberty. Toxicol Mech Methods. 2016;26(7):493-500.
Dong RH, Zhang H, Zhang MR, Chen JS, Min W, Li SG, et al. Association between phthalate exposure and the use of plastic containers in Shanghai adults. Biomed Environ Sci. 2017;30(10):727-36.
Durmaz E, Aşçı A, Erkekoğlu P, Akçurin S, Gümüşel BK, Bircan İ. Urinary bisphenol a levels in girls with idiopathic central precocious puberty. J Clin Res Pediatr Endocrinol. 2014;6(1):16.
Durmaz E, Özmert EN, Erkekoğlu P, Giray B, Derman O, Hıncal F, et al. Plasma phthalate levels in pubertal gynecomastia. Pediatrics. 2010;125(1):e122-e9.
Franken C, Lambrechts N, Govarts E, Koppen G, Den Hond E, Ooms D, et al. Phthalate-induced oxidative stress and association with asthma-related airway inflammation in adolescents. Int J Hyg Environ Health. 2017;220(2):468-77.
Kondolot M, Ozmert EN, Ascı A, Erkekoglu P, Oztop DB, Gumus H, et al. Plasma phthalate and bisphenol a levels and oxidant-antioxidant status in autistic children. Environ Toxicol Pharmacol. 2016;43:149-58.
Stojanoska MM, Milosevic N, Milic N, Abenavoli L. The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders. Endocrine. 2017;55(3):666-81.
Olesen IA, Sonne SB, Hoei-Hansen CE, Rajpert-DeMeyts E, Skakkebaek NE. Environment, testicular dysgenesis and carcinoma in situ testis. Review Best Pract Res Clin Endocrinol Metab. 2007;21(3):462-78.
Frederiksen H, Skakkebaek NE, Andersson AM. Metabolism of phthalates in humans. Mol Nutr Food Res. 2007;51(7):899-911.
Erkekoğlu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F. Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic Biol Med. 2010;49(4):559-66.
Erkekoglu P, Rachidi W, Yuzugullu OG, Giray B, Favier A, Ozturk M, et al. Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol Appl Pharmacol. 2010;248(1):52-62.
Heindel JJ, Powell CJ. Phthalate ester effects on rat Sertoli cell function in vitro: effects of phthalate side chain and age of animal. Toxicol Appl Pharmacol. 1992;115(1):116-23.
Koch HM, Bolt HM, Preuss R, Angerer J. New metabolites of di (2-ethylhexyl) phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol. 2005;79(7):367-76.
Rusyn I, Peters JM, Cunningham ML. Modes of action and species-specific effects of di-(2-ethylhexyl) phthalate in the liver. Crit Rev Toxicol. 2006;36(5):459-79.
Lassen C, Maag J, Hubschmann LB, Hansen E, Searl A, Doust E, et al. Data on manufacture, import, export, uses and releases of Bis(2-ethylhexyl) phthalate (DEHP) as well as information on potential alternatives to its use. COWI, IOM & Entec report to ECHA 2009.
Tickner JA, Schettler T, Guidotti T, McCally M, Rossi M. Health risks posed by use of Di‐2‐ethylhexyl phthalate (DEHP) in PVC medical devices: A critical review. Am J Ind Med. 2001;39(1):100-11.
CJ FF, Palmero D, M'Madi F, Tolsa J. Phthalate exposure in the neonatal intensive care unit. Arch Pediatr. 2014;22(2):203-10.
Rock G, Labow RS, Tocchi M. Distribution of di (2-ethylhexyl) phthalate and products in blood and blood components. Environ Health Perspect. 1986;65:309-16.
Shelby MD. NTP-CERHR monograph on the potential human reproductive and developmental effects of di (2-ethylhexyl) phthalate (DEHP). NTP CERHR MON. 2006 Nov;(18):v, vii-7, II-iii-xiii passim. PMID: 19407857.
Shea KM, Health CoE. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics. 2003;111(6):1467-74.
Albro PW, Hass JR, Peck CC, Odam DG, Corbett JT, Bailey FJ, et al. Identification of the metabolites of di-(2-ethylhexyl) phthalate in urine from the African green monkey. Drug Metab Dispos. 1981;9(3):223-5.
Albro PW, Lavenhar SR. Metabolism of di(2-ethylhexyl)phthalate. Drug Metab Rev. 1989;21(1):13-34.
Albro PW, Moore B. Identification of the metabolites of simple phthalate diesters in rat urine. J Chromatogr. 1974;94(0):209-18.
Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, et al. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di (2-ethylhexyl) phthalate. Reprod Toxicol. 2002;16(5):529-653.
Koch HM, Bolt HM, Angerer J. Di (2-ethylhexyl) phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol. 2004;78(3):123-30.
Preuss R, Koch HM, Angerer J. Biological monitoring of the five major metabolites of di-(2-ethylhexyl) phthalate (DEHP) in human urine using column-switching liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;816(1-2):269-80.
Barr DB, Silva MJ, Kato K, Reidy JA, Malek NA, Hurtz D, et al. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect.2003;111(9):1148-51.
Silva MJ, Barr DB, Reidy JA, Kato K, Malek NA, Hodge CC, et al. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch Toxicol. 2003;77(10):561-7.
IARC [Internet]. Di(2-ethylhexyl)phthalate; 2018 [cited 2021 Oct 10]. Available from: https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono101-006.pdf.>
European Comission [Internet]. Food Contact Materials; 2004 [cited 2021 Oct 10]. Available from: https://ec.europa.eu/food/safety/chemical-safety/food-contact-materials/legislation_en.>
65 P [Internet]. Safe Drinking Water and Toxic Enforcement Act of 1986; 1986 [cited 2021 Oct 10]. Available from: https://www.p65warnings.ca.gov/about/frequently-asked-questions.>
Calafat AM, McKee RH. Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di (2-ethylhexyl) phthalate] as a case study. Environ Health Perspect. 2006;114(11):1783-9.
Kato K, Silva MJ, Reidy JA, Hurtz D, 3rd, Malek NA, Needham LL, et al. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect. 2004;112(3):327-30.
Silva MJ, Samandar E, Reidy JA, Hauser R, Needham LL, Calafat AM. Metabolite profiles of di-n-butyl phthalate in humans and rats. Environ Sci Technol. 2007;41(21):7576-80.
The EFSA Journal is a publication of the European Food Safety Authority [Internet]. Draft update of the risk assessment of di-butylphthalate (DBP), butyl-benzyl-phthalate (BBP), bis(2-ethylhexyl)phthalate (DEHP), di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP) for use in food contact materials; 2019 [cited 2021 Oct 10]. Available from: https://www.efsa.europa.eu/sites/default/files/consultation/consultation/Phthalates_in_plastic_FCM_draft_opinion_for_public_consultation.pdf.>
Sekizawa, Jun, Dobson, Stuart, Touch, Ralph J, Sekizawa, Jun, Dobson, Stuart. et al. Diethyl phthalate. World Health Organization. 2003.
Verschueren K. Handbook of Environmental Data on Organic Chemicals. Van Norstrand Reinhold Co. Inc: New York and Toronto. 1983. 1310 p.
Hawley GG, Lewis RJ. Condensed chemical dictionary: Wiley: New York. 2001. 1380 p.
Wahl HG, Hoffmann A, Häring H-U, Liebich HM. Identification of plasticizers in medical products by a combined direct thermodesorption–cooled injection system and gas chromatography–mass spectrometry. J Chromatogr A. 1999;847(1-2):1-7.
Foster PM, Thomas LV, Cook MW, Gangolli SD. Study of the testicular effects and changes in zinc excretion produced by some n-alkyl phthalates in the rat. oxicol Appl Pharmacol. 1980;54(3):392-8.
Foster P, Lake B, Thomas LV, Cook M, Gangolli S. Studies on the testicular effects and zinc excretion produced by various isomers of monobutyl-o-phthalate in the rat. Chem Biol Interact. 1981;34(2):233-8.
Gray Jr LE, Ostby J, Furr J, Price M, Veeramachaneni DR, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci. 2000;58(2):350-65.
The Council Of The European Communities [Internet]. Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products; 1976 [cited 2021 Oct 10]. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31976L0768:EN:HTML>
Api AM. Toxicological profile of diethyl phthalate: a vehicle for fragrance and cosmetic ingredients. Food Chem Toxicol. 2001;39(2):97-108.
Wallace DR. Dibutyl phthalate. Encyclopedia of Toxicology: Elsevier: The Netherlands. 2005. 2000 p.
Toft G, Jönsson BA, Lindh CH, Jensen TK, Hjollund NH, Vested A, et al. Association between pregnancy loss and urinary phthalate levels around the time of conception. Environ Health Perspect. 2012;120(3):458-63.
Mikuriya H, Ikemoto I, Tanaka A. Urinary metabolites contributing to testicular damage induced by butylbenzyl phthalate. Jikeikai Med J. 1988;35:403-9.
Eigenberg DA, Bozigian HP, Carter DE, Sipes IG. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat. J Toxicol Environ Health. 1986;17(4):445-56.
Zacharewski TR, Meek MD, Clemons JH, Wu Z, Fielden MR, Matthews JB. Examination of the in vitro and in vitro estrogenic activities of eight commercial phthalate esters. Toxicol Sci. 1998;46(2):282-93.
Picard K, Lhuguenot J-C, Lavier-Canivenc M-C, Chagnon M-C. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule (s). Toxicol Appl Pharmacol. 2001;172(2):108-18.
European Chemicals Agency [Internet]. Diisobutyl phthalate; 2017 [cited 2021 Oct 10]. Available from: https://echa.europa.eu/substance-information/-/substanceinfo/100.001.412.>
Lyche JL, Gutleb AC, Bergman Å, Eriksen GS, Murk AJ, Ropstad E, et al. Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev. 2009;12(4):225-49.
Lorber M, Koch HM. Development and application of simple pharmacokinetic models to study human exposure to di-n-butyl phthalate (DnBP) and diisobutyl phthalate (DiBP). Environ Int. 2013;59:469-77.
Koch H, Christensen K, Harth V, Lorber M, Brüning T. Di-n-butyl phthalate (DnBP) and diisobutyl phthalate (DiBP) metabolism in a human volunteer after single oral doses. Arch Toxicol. 2012;86(12):1829-39.
Koopman P, Münsterberg A, Capel B, Vivian N, Lovell-Badge R. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature. 1990;348(6300):450-2.
Capel B. The battle of the sexes. Mech Dev. 2000;92(1):89-103.
Koopman P. Gonad development: signals for sex. Curr Biol. 2001;11(12):R481-R3.
Bullejos M, Bowles J, Koopman P. Searching for missing pieces of the sex-determination puzzle. J Exp Zool. 2001;290(5):517-22.
Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol. 2003;200(3):370-4.
Nistal M, Gonzalez-Peramato P, Regadera J, Serrano A, Tarin V, De Miguel MP. Primary testicular lesions are associated with testicular germ cell tumors of adult men. Am J Surg Pathol. 2006;30(10):1260-8.
Ferrara D, Hallmark N, Scott H, Brown R, McKinnell C, Mahood IK, et al. Acute and long-term effects of in utero exposure of rats to di (n-butyl) phthalate on testicular germ cell development and proliferation. Endocrinology. 2006;147(11):5352-62.
Barlow NJ, Foster PM. Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to di (n-butyl) phthalate. Toxicol Pathol. 2003;31(4):397-410.
Kleymenova E, Swanson C, Boekelheide K, Gaido KW. Exposure in utero to di (n-butyl) phthalate alters the vimentin cytoskeleton of fetal rat Sertoli cells and disrupts Sertoli cell-gonocyte contact. Biol Reprod. 2005;73(3):482-90.
Codesal J, Regadera J, Nistal M, Regadera-Sejas J, Paniagua R. Involution of human fetal Leydig cells. An immunohistochemical, ultrastructural and quantitative study. J Anat. 1990;172:103.
Kerr JB. A light microscopic and morphometric analysis of the Sertoli cell during the spermatogenic cycle of the rat. Anat Embryol (Berl). 1988;177(4):341-8.
Zhang FP, Pakarainen T, Zhu F, Poutanen M, Huhtaniemi I. Molecular characterization of postnatal development of testicular steroidogenesis in luteinizing hormone receptor knockout mice. Endocrinology. 2004;145(3):1453-63.
Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol. 2001;15(1):172-83.
Lei Z, Mishra S, Zou W, Xu B, Foltz M, Li X, et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol. 2001;15(1):184-200.
Ariyaratne HS, Mendis-Handagama SC, Hales DB, Mason JI. Studies on the Onset of Leydig Precursor Cell Differentiation in the Prepubertal Rat Testis1. Biol Reprod. 2000;63(1):165-71.
Ge R, Shan L, Hardy M. Pubertal development of Leydig cells. The Leydig Cell. AH Payne, MP Hardy, and LD Russell, editors. 1996;1:159-74.
Latini G, Del Vecchio A, Massaro M, Verrotti A, De Felice C. Phthalate exposure and male infertility. Toxicology. 2006;226(2-3):90-8.
Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human ‘testicular dysgenesis syndrome’: a possible model using in‐utero exposure of the rat to dibutyl phthalate. Hum Reprod. 2003;18(7):1383-94.
Aarskog D. Clinical and cytogenetic studies in hypospadias. Acta Paediatr Scand Suppl. 1970;203:Suppl 203:1+. PMID: 4319049.
Scully R. Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Ped Adolesc Endocrinol. 1981;8:203-17.
Savage M, Lowe D. Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol (Oxf). 1990;32(4):519-34.
Müller J, Skakkebaek NE. Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J (Clin Res Ed). 1984;288(6428):1419.
Müller J, Skakkebaek NE, Ritzén M, Plöen L, Petersen KE. Carcinoma in situ of the testis in children with 45, X/46, XY gonadal dysgenesis. J Pediatr. 1985;106(3):431-6.
Cassio A, Cacciari E, D'Errico A, Balsamo A, Grigioni FW, Pascucci MG, et al. Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. Acta Endocrinol (Copenh). 1990;123(4):416-22.
Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol. 1991;10(2):126-44.
Ramani P, Yeung CK, Habeebu SS. Testicular intratubular germ cell neoplasia in children and adolescents with intersex. Am J Surg Pathol. 1993;17(11):1124-33.
Słowikowska‐Hilczer J, Szarras‐Czapnik M, Kula K. Testicular pathology in 46, XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer. J Androl. 2001;22(5):781-92.
Słowikowska‐Hilczer J, Romer TE, Kula K. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl. 2003;24(2):270-8.
Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev. 2006;27(5):468-84.
Müller J, Visfeldt J, Philip J, Skakkebæk NE. Carcinoma in situ, gonadoblastoma, and early invasive neoplasia in a nine‐year‐old girl with 46, XY gonadal dysgenesis. APMIS. 1992;100(1‐6):170-4.
Jørgensen N, Müller J, Jaubert F, Clausen OP, Skakkebaek NE. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology. 1997;30(2):177-86.
Cools M, Stoop H, Kersemaekers AMF, Drop SL, Wolffenbuttel KP, Bourguignon JP, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab. 2006;91(6):2404-13.
Hannema S, Scott I, Rajpert‐De Meyts E, Skakkebaek N, Coleman N, Hughes I. Testicular development in the complete androgen insensitivity syndrome. J Pathol. 2006;208(4):518-27.
Rajpert-De Meyts E, Skakkebaek N. The possible role of sex hormones in the development of testicular cancer. Eur Urol. 1993;23:51-61.
Adham IM, Burkhardt E, Benahmed M, Engel W. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem. 1993;268(35):26668-72.
Ferlin A, Arredi B, Zuccarello D, Garolla A, Selice R, Foresta C. Paracrine and endocrine roles of insulin-like factor 3. J Endocrinol Invest. 2006;29(7):657-64.
Veeramachaneni DR, Klinefelter GR. Phthalate-induced pathology in the foetal testis involves more than decreased testosterone production. Reproduction. 2014;147(4):435-42.
Li L-H, Jester Jr WF, Orth JM. Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured Sertoli cells and gonocytes from neonatal rats. Toxicol Appl Pharmacol. 1998;153(2):258-65.
Wang H, Wang J, Zhang J, Jin S, Li H. Role of PI3K/AKT/mTOR signaling pathway in DBP-induced apoptosis of testicular sertoli cells in vitro. Environ Toxicol Pharmacol. 2017;53:145-150.
Mylchreest E, Cattley RC, Foster PM. Male reproductive tract malformations in rats following gestational and lactational exposure to di (n-butyl) phthalate: an antiandrogenic mechanism? Toxicol Sci. 1998;43(1):47-60.
Mylchreest E, Sar M, Cattley RC, Foster PM. Disruption of androgen-regulated male reproductive development by di (n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol. 1999;156(2):81-95.
Mylchreest E, Foster P. DBP exerts its antiandrogenic activity by indirectly interfering with androgen signaling pathways. Toxicol Appl Pharmacol. 2000;168(2):174-5.
Mylchreest E, Wallace DG, Cattley RC, Foster PM. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di (n-butyl) phthalate during late gestation. Toxicol Sci. 2000;55(1):143-51.
Mylchreest E, Sar M, Wallace DG, Foster PM. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di (n-butyl) phthalate. Reprod Toxicol. 2002;16(1):19-28.
Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci. 2000;58(2):339-49.
Skakkebaek NE, Holm M, Hoei-Hansen C, Jørgensen N, Rajpert-De Meyts E. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. Apmis. 2003;111(1):1-9; discussion 9-11.
Mahood IK, Hallmark N, McKinnell C, Walker M, Fisher JS, Sharpe RM. Abnormal Leydig cell aggregation in the fetal testis of rats exposed to di (n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology. 2005;146(2):613-23.
Sohoni P, Sumpter J. Several environmental oestrogens are also anti-androgens. J Endocrinol. 1998;158(3):327-40.
Li L, Bu T, Su H, Chen Z, Liang Y, Zhang G, et al. In utero exposure to diisononyl phthalate caused testicular dysgenesis of rat fetal testis. Toxicol Lett. 2015;232(2):466-74.
Erkekoglu P, Zeybek ND, Giray B, Asan E, Hincal F. The effects of di (2-ethylhexyl) phthalate exposure and selenium nutrition on sertoli cell vimentin structure and germ-cell apoptosis in rat testis. Arch Environ Contam Toxicol. 2012;62(3):539-47.
Balcı A, Özkemahlı G, Erkekoglu P, Zeybek D, Yersal N, Kocer-Gumusel B. Effects of prenatal and lactational bisphenol a and/or di (2-ethylhexyl) phthalate exposure on male reproductive system. Int J Environ Health Res. 2020:1-14.
Balci A, Ozkemahli G, Erkekoglu P, Zeybek ND, Yersal N, Kocer-Gumusel B. Histopathologic, apoptotic and autophagic, effects of prenatal bisphenol A and/or di (2-ethylhexyl) phthalate exposure on prepubertal rat testis. Environ Sci Pollut Res Int. 2020;27(16):20104-16.
Sung CR, Kang HG, Hong JY, Kwack SJ. Citrate ester substitutes for di-2-ethylhexyl phthalate: In vivo reproductive and in vitro cytotoxicity assessments. J Toxicol Environ Health A. 2020;83(17-18):589-595.
Jatkowska N, Kudłak B, Lewandowska P, Liu W, Williams MJ, Schiöth HB. Identification of synergistic and antagonistic actions of environmental pollutants: Bisphenols A, S and F in the presence of DEP, DBP, BADGE and BADGE·2HCl in three component mixtures. Sci Total Environ. 2021;767:144286.
Tassinari R, Tait S, Busani L, Martinelli A, Valeri M, Gastaldelli A, et al. The Life Persuaded Project Group. Toxicological Assessment of Oral Co-Exposure to Bisphenol A (BPA) and Bis(2-ethylhexyl) Phthalate (DEHP) in Juvenile Rats at Environmentally Relevant Dose Levels: Evaluation of the Synergic, Additive or Antagonistic Effects. Int J Environ Res Public Health. 2021;18(9):4584.
Baralić K, Živančević K, Jorgovanović D, Javorac D, Radovanović J, Gojković T, et al. Probiotic reduced the impact of phthalates and bisphenol A mixture on type 2 diabetes mellitus development: Merging bioinformatics with in vivo analysis. Food Chem Toxicol. 2021;154:112325
Baralić K, Jorgovanović D, Živančević K, Buha Djordjević A, Antonijević Miljaković E, Miljković M, et al. Combining in vivo pathohistological and redox status analysis with in silico toxicogenomic study to explore the phthalates and bisphenol A mixture-induced testicular toxicity. Chemosphere. 2021;267:129296.
Ma L, Mo J, Chen Y, Li L, Xie L, Chen X, et al. In utero cadmium and dibutyl phthalate combination exposure worsens the defects of fetal testis in rats. Environ Pollut. 2020;265(Pt A):114842.
Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology. 7(6):682-91.
Pant N, Shukla M, Patel DK, Shukla Y, Mathur N, Gupta YK, et al. Correlation of phthalate exposures with semen quality. Toxicol Appl Pharmacol. 2008;231(1):112-6.
Pant N, Pant A, Shukla M, Mathur N, Gupta Y, Saxena D. Environmental and experimental exposure of phthalate esters: the toxicological consequence on human sperm. Hum Exp Toxicol. 2011;30(6):507-14.
Zhang Y-H, Zheng L-X, Chen B-H. Phthalate exposure and human semen quality in Shanghai: a cross-sectional study. Biomed Environ Sci. 2006;19(3):205-9.
Wolff MS, Teitelbaum SL, Pinney SM, Windham G, Liao L, Biro F, et al. Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspect. 2010;118(7):1039-46.
Huang P-C, Tsai E-M, Li W-F, Liao P-C, Chung M-C, Wang Y-H, et al. Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis. Hum Reprod. 2010;25(4):986-94.
Weuve J, Hauser R, Calafat AM, Missmer SA, Wise LA. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999–2004. Environ Health Perspect. 2010;118(6):825-32.
Kim Y, Ha EH, Kim EJ, Park H, Ha M, Kim JH, et al. Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children’s Environmental Health (MOCEH) study. Environ Health Perspect. 2011;119(10):1495-500.
Whyatt RM, Liu X, Rauh VA, Calafat AM, Just AC, Hoepner L, et al. Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ Health Perspect. 2012;120(2):290-5.
Engel SM, Miodovnik A, Canfield RL, Zhu C, Silva MJ, Calafat AM, et al. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect. 2010;118(4):565-71.
Kim B-N, Cho S-C, Kim Y, Shin M-S, Yoo H-J, Kim J-W, et al. Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biol Psychiatry. 2009;66(10):958-63.
Miodovnik A, Edwards A, Bellinger DC, Hauser R. Developmental neurotoxicity of ortho-phthalate diesters: review of human and experimental evidence. Neurotoxicology. 2014;41:112-22.
Holm M, Rajpert‐De Meyts E, Andersson AM, Skakkebæk NE. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio. J Pathol. 2003;199(3):378-86.
Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056-61.
Sunman B, Yurdakök K, Kocer-Gumusel B, Özyüncü Ö, Akbıyık F, Balcı A, et al. Prenatal bisphenol a and phthalate exposure are risk factors for male reproductive system development and cord blood sex hormone levels. Reprod Toxicol. 2019;87:146-55.
Eurpean Comission [Internet]. REACH Restrictions. Internal Market, Industry, Entrepreneurship and SMEs. [cited 2021 Dec 07]. Available from: https://ec.europa.eu/growth/sectors/chemicals/reach/restrictions_en>
Turkish Republic Ministry of Industry and Trade [Internet]. Hazardous Chemical Content Of Some Consumer Products Communiqué On Market Supervision And Audit [cited 2021 Dec 07]. Available from: https://www.resmigazete.gov.tr/eskiler/2011/04/20110402-9.htm>
